|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4188 | (2006.01) |
| A61K 31/55 | (2006.01) | ||
| A61P 5/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07F 9/6506 | (2006.01) |
| (11) | Number of the document | 2523731 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11702096.6 |
| Date of filing the European patent application | 2011-01-13 | |
| (97) | Date of publication of the European application | 2012-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation | 2019-02-11 |
| (86) | Number | PCT/US2011/021100 |
| Date | 2011-01-13 |
| (87) | Number | WO 2011/088188 |
| Date | 2011-07-21 |
| (30) | Number | Date | Country code |
| 294980 P | 2010-01-14 | US |
| (72) |
HU, Qi-Ying, US
KSANDER, Gary, US
MEREDITH, Erik, US
MONOVICH, Lauren G., US
PAPILLON, Julien, US
SCHUMACHER, Christoph, CH
|
| (73) |
Recordati AG,
Lindenstrasse 8, 6340 Baar,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antinksčių hormoną modifikuojančio agento panaudojimas |
| USE OF AN ADRENAL HORMONE-MODIFYING AGENT |
| Payment date | Validity (years) | Amount | |
| 2025-12-04 | 16 | 347.00 EUR |
| 2027-01-13 |